165 related articles for article (PubMed ID: 11882579)
1. Upregulation of arterial serotonin 1B and 2B receptors in deoxycorticosterone acetate-salt hypertension.
Banes AK; Watts SW
Hypertension; 2002 Feb; 39(2 Pt 2):394-8. PubMed ID: 11882579
[TBL] [Abstract][Full Text] [Related]
2. Enhanced contraction to 5-hydroxytryptamine is not due to "unmasking" of 5-hydroxytryptamine(1b) receptors in the mesenteric artery of the deoxycorticosterone acetate-salt rat.
Banes AK; Watts SW
Hypertension; 2001 Oct; 38(4):891-5. PubMed ID: 11641304
[TBL] [Abstract][Full Text] [Related]
3. Is functional upregulation of the 5-HT2B receptor in deoxycorticosterone acetate salt-treated rats blood pressure dependent?
Watts SW; Harris B
Gen Pharmacol; 1999 Dec; 33(6):439-47. PubMed ID: 10647769
[TBL] [Abstract][Full Text] [Related]
4. Arterial expression of 5-HT2B and 5-HT1B receptors during development of DOCA-salt hypertension.
Banes AK; Watts SW
BMC Pharmacol; 2003 Sep; 3():12. PubMed ID: 12974983
[TBL] [Abstract][Full Text] [Related]
5. 5-Hydroxytryptamine2B receptor mediates contraction in the mesenteric artery of mineralocorticoid hypertensive rats.
Watts SW; Gilbert L; Webb RC
Hypertension; 1995 Dec; 26(6 Pt 2):1056-9. PubMed ID: 7498967
[TBL] [Abstract][Full Text] [Related]
6. The development of enhanced arterial serotonergic hyperresponsiveness in mineralocorticoid hypertension.
Watts SW
J Hypertens; 1998 Jun; 16(6):811-22. PubMed ID: 9663921
[TBL] [Abstract][Full Text] [Related]
7. 5-HT2B-receptor antagonist LY-272015 is antihypertensive in DOCA-salt-hypertensive rats.
Watts SW; Fink GD
Am J Physiol; 1999 Mar; 276(3):H944-52. PubMed ID: 10070078
[TBL] [Abstract][Full Text] [Related]
8. Serotonin-induced contraction in mesenteric resistance arteries: signaling and changes in deoxycorticosterone acetate-salt hypertension.
Watts SW
Hypertension; 2002 Mar; 39(3):825-9. PubMed ID: 11897772
[TBL] [Abstract][Full Text] [Related]
9. Arterial 5-hydroxytryptamine transporter function is impaired in deoxycorticosterone acetate and Nomega-nitro-L-arginine but not spontaneously hypertensive rats.
Ni W; Lookingland K; Watts SW
Hypertension; 2006 Jul; 48(1):134-40. PubMed ID: 16754787
[TBL] [Abstract][Full Text] [Related]
10. The 5-hydroxytryptamine2B receptor and 5-HT receptor signal transduction in mesenteric arteries from deoxycorticosterone acetate-salt hypertensive rats.
Watts SW; Baez M; Webb RC
J Pharmacol Exp Ther; 1996 May; 277(2):1103-13. PubMed ID: 8627522
[TBL] [Abstract][Full Text] [Related]
11. One-month serotonin infusion results in a prolonged fall in blood pressure in the deoxycorticosterone acetate (DOCA) salt hypertensive rat.
Davis RP; Szasz T; Garver H; Burnett R; Tykocki NR; Watts SW
ACS Chem Neurosci; 2013 Jan; 4(1):141-8. PubMed ID: 23336053
[TBL] [Abstract][Full Text] [Related]
12. Mineralocorticoids upregulate arterial contraction to epidermal growth factor.
Florian JA; Dorrance A; Webb RC; Watts SW
Am J Physiol Regul Integr Comp Physiol; 2001 Sep; 281(3):R878-86. PubMed ID: 11507004
[TBL] [Abstract][Full Text] [Related]
13. 5-hydroxytryptamine (5-HT) reduces total peripheral resistance during chronic infusion: direct arterial mesenteric relaxation is not involved.
Davis RP; Pattison J; Thompson JM; Tiniakov R; Scrogin KE; Watts SW
BMC Pharmacol; 2012 May; 12():4. PubMed ID: 22559843
[TBL] [Abstract][Full Text] [Related]
14. Arterial epidermal growth factor receptor expression in deoxycorticosterone acetate-salt hypertension.
Northcott C; Florian JA; Dorrance A; Watts SW
Hypertension; 2001 Dec; 38(6):1337-41. PubMed ID: 11751714
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of receptor-operated cation current and TRPC6 expression in arterial smooth muscle cells of deoxycorticosterone acetate-salt hypertensive rats.
Bae YM; Kim A; Lee YJ; Lim W; Noh YH; Kim EJ; Kim J; Kim TK; Park SW; Kim B; Cho SI; Kim DK; Ho WK
J Hypertens; 2007 Apr; 25(4):809-17. PubMed ID: 17351373
[TBL] [Abstract][Full Text] [Related]
16. 5-Hydroxytryptamine(2B) receptor function is enhanced in the N(omega)-nitro-L-arginine hypertensive rat.
Russell A; Banes A; Berlin H; Fink GD; Watts SW
J Pharmacol Exp Ther; 2002 Oct; 303(1):179-87. PubMed ID: 12235249
[TBL] [Abstract][Full Text] [Related]
17. 5-Hydroxytryptamine lowers blood pressure in normotensive and hypertensive rats.
Diaz J; Ni W; Thompson J; King A; Fink GD; Watts SW
J Pharmacol Exp Ther; 2008 Jun; 325(3):1031-8. PubMed ID: 18305011
[TBL] [Abstract][Full Text] [Related]
18. The 5-hydroxytryptamine2A receptor is involved in (+)-norfenfluramine-induced arterial contraction and blood pressure increase in deoxycorticosterone acetate-salt hypertension.
Ni W; Fink GD; Watts SW
J Pharmacol Exp Ther; 2007 May; 321(2):485-91. PubMed ID: 17289838
[TBL] [Abstract][Full Text] [Related]
19. Gender differences in vascular reactivity to endothelin-1 in deoxycorticosterone-salt hypertensive rats.
Tostes RC; David FL; Carvalho MH; Nigro D; Scivoletto R; Fortes ZB
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S99-101. PubMed ID: 11078348
[TBL] [Abstract][Full Text] [Related]
20. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
Li JS; Turgeon A; Schiffrin EL
Am J Hypertens; 1998 May; 11(5):554-62. PubMed ID: 9633791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
